Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1996 Dec;51(12):1270–1272. doi: 10.1136/thx.51.12.1270

Gastrin levels in serum and bronchoalveolar lavage fluid of patients with lung cancer: comparison with patients with chronic obstructive pulmonary disease.

A Dowlati 1, T Bury 1, J L Corhay 1, T Weber 1, A Lamproye 1, P Mendes 1, M Radermecker 1
PMCID: PMC472776  PMID: 8994528

Abstract

BACKGROUND: The gastrin gene is known to be expressed in all classes of bronchogenic carcinomas. Furthermore, high levels of gastrin have been reported in both the bronchoalveolar lavage (BAL) fluid and serum of patients with lung cancer. Based on these preliminary data a study was conducted to evaluate the usefulness of gastrin measurements in the diagnosis and staging of lung cancer. METHODS: Thirty-five patients with lung cancer (26 non-small cell (NSCLC) and nine small cell (SCLC)) and 25 patients with chronic obstructive pulmonary disease underwent fibreoptic bronchoscopy and BAL. Gastrin levels were determined in both BAL fluid and the serum and compared with each other and with staging. RESULTS: No difference was found between the gastrin levels in the BAL fluid or serum of the study groups. There was no correlation with the stage in NSCLC and no correlation was found between the gastrin levels in the serum and the BAL fluid. A significant difference was seen in gastrin levels in BAL fluid between extensive and limited SCLC (p < 0.05). CONCLUSION: There is no evidence of clinical usefulness for gastrin measurements in lung cancer.

Full text

PDF
1270

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clinical guidelines and indications for bronchoalveolar lavage (BAL): Report of the European Society of Pneumology Task Group on BAL. Eur Respir J. 1990 Sep;3(8):937–976. [PubMed] [Google Scholar]
  2. Dowlati A., Bury T., Corhay J. L., Weber T., Mendes P., Radermecker M. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging. Cancer. 1996 May 15;77(10):2039–2043. doi: 10.1002/(SICI)1097-0142(19960515)77:10<2039::AID-CNCR11>3.0.CO;2-W. [DOI] [PubMed] [Google Scholar]
  3. Gewirtz G., Yalow R. S. Ectopic ACTH production in carcinoma of the lung. J Clin Invest. 1974 Apr;53(4):1022–1032. doi: 10.1172/JCI107639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hansen M., Rehfeld J. F., Stadil F. Small cell carcinoma of the lung: relation of calcitonin to bone marrow metastases, parathormone and gastrin. Acta Med Scand. 1979;206(3):215–218. doi: 10.1111/j.0954-6820.1979.tb13497.x. [DOI] [PubMed] [Google Scholar]
  5. Rees L. H., Bloomfield G. A., Rees G. M., Corrin B., Franks L. M., Ratcliffe J. G. Multiple hormones in a bronchial tumor. J Clin Endocrinol Metab. 1974 Jun;38(6):1090–1097. doi: 10.1210/jcem-38-6-1090. [DOI] [PubMed] [Google Scholar]
  6. Rehfeld J. F., Bardram L., Hilsted L. Gastrin in human bronchogenic carcinomas: constant expression but variable processing of progastrin. Cancer Res. 1989 Jun 1;49(11):2840–2843. [PubMed] [Google Scholar]
  7. Sethi T., Rozengurt E. Gastrin stimulates Ca2+ mobilization and clonal growth in small cell lung cancer cells. Cancer Res. 1992 Nov 1;52(21):6031–6035. [PubMed] [Google Scholar]
  8. Zhou Q., Yang Z., Yang J., Tian Z., Zhang H. The diagnostic significance of gastrin measurement of bronchoalveolar lavage fluid for lung cancer. J Surg Oncol. 1992 Jun;50(2):121–124. doi: 10.1002/jso.2930500214. [DOI] [PubMed] [Google Scholar]
  9. Zhou Q., Zhang H., Pang X., Yang J., Tain Z., Wu Z., Yang Z. Pre- and postoperative sequential study on the serum gastrin level in patients with lung cancer. J Surg Oncol. 1992 Sep;51(1):22–25. doi: 10.1002/jso.2930510108. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES